Below the Belt highlights patients' stories and the push for new research dollars for this poorly understood disease. Here are seven surprising facts from the film.

In 2013, John Kindschuh was admitted to a hospital in St. Louis with dizziness. His roommate alerted staff that his condition — later diagnosed as a massive stroke — was deteriorating.

In a large study, the experimental drug donanemab slowed the progression of Alzheimer's by about 35%. That's slightly better than the drug Leqembi, which was fully approved by the FDA on July 6.

From convenience stores to online, the tablet "will be an available option for millions of people in the United States," the director of the FDA's Center for Drug Evaluation and Research says.

The country's toll makes up nearly a third of the world's 619,000 malaria deaths each year. Now Nigeria has approved a new vaccine. Will it get into the arms of those who need it most?

Taken after sex, the antibiotic doxycycline can ward off some sexually transmitted illnesses. Doctors are already prescribing it and the CDC is expected to share guidance soon for how best to use it.

As money is funneled to states, opioid councils wield significant power in determining how it gets spent. They face concerns about conflicts of interest and lack of representation by affected groups.

Calliope Holingue researches how the microbiome and mind affect each other. She's part of a growing field, exploring how that connection could ultimately improve treatments for mental conditions.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

Alicia Roth Weigel is one of three activists profiled in Julie Cohen's new documentary. She says intersex is an umbrella term for people whose "anatomy doesn't fit super neatly into a binary box."

The state's abortion bans make no exceptions for fatal fetal anomalies. Two women had devastating pregnancy diagnoses — one could leave the state for an abortion, and the other could not.

It's already harder to get an abortion in many places and access is likely to be limited more with the passage of new laws.

A new CDC report finds that just a third of those diagnosed with hepatitis C have cleared the virus — a decade after a cure was made available.

New research calls into question prescribing the drugs even for short-term pain relief – especially given the risk of addiction.